The unique nanoparticle technology of GTx-104 facilitates aqueous formulation of insoluble nimodipine for a standard peripheral IV infusion. GTx-104 provides ... concentrated oral-mucosal spray of ...

GTx-102 is a novel, concentrated oral-mucosal spray of betamethasone intended to ... GTx-104, is an intravenous infusion targeting aneurysmal Subarachnoid Hemorrhage (aSAH), a rare and life ...

Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug Application (NDA) Submission Anticipated First Half of ...

Diazepam (Valium), pentobarbital, betamethasone, mannitol ... individuals with an as-needed scheduling or continuous IV drip. While the patient is in the ICU, IV medication may be preferred ...

GTx-102 is a novel, concentrated oral-mucosal spray of betamethasone intended to improve neurological ... Grace Therapeutics’ lead clinical asset, GTx-104, is an intravenous infusion targeting ...

IV therapy has been used for decades in hospitals to treat a range of conditions, from dehydration to nutrient-absorption disorders, but it's increasingly offered at independent clinics and ...

Reducing intravenous (IV) isatuximab delivery from 75 minutes to 30 minutes could provide a wealth of benefits to patients ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering ...

Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...

A new report about the The Elder Scrolls IV: Oblivion Remake has revealed when the game is releasing, and it’s soon. The report doesn’t provide a precise release date, but a release window.

Figuring out how to stop post-nasal drip quickly can help mitigate the other uncomfortable symptoms of the phenomenon, like sore throat or stomach upset. While post-nasal drip is typically a mild ...

Dr. Russell Petrak, managing senior partner of Metro Infusion Center, calls on Blue Cross Blue Shield to continue covering ...